GRAPPA 2022 Patient Research Partners Network Update: Managing Growth

Area of Science:

• Rheumatology
• Patient-Centered Research
• Dermatology

Background:

• The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) convened its 2022 annual meeting.
• This marked the first in-person gathering since the onset of the coronavirus disease 2019 (COVID-19) pandemic.
• Patient research partners (PRPs) are integral to the GRAPPA initiative.

Purpose of the Study:

• To summarize the activities of the GRAPPA Patient Research Partner (PRP) Network.
• To highlight the continued engagement of PRPs in advancing GRAPPA's mission.
• To document the participation of PRPs in the 2022 GRAPPA annual meeting.

Main Methods:

• Attendance of seven PRPs at the 2022 GRAPPA annual meeting.
• Review of ongoing activities within the GRAPPA PRP Network.
• Reporting on the commitment of PRPs to patient-centered research.

Main Results:

• Seven PRPs actively participated in the 2022 GRAPPA annual meeting.
• The GRAPPA PRP Network demonstrated sustained engagement and commitment.
• The network continues to provide valuable patient perspectives to support GRAPPA's objectives.

Conclusions:

• The GRAPPA PRP Network remains a vital component of the GRAPPA initiative.
• In-person meetings facilitate robust collaboration between researchers and patient partners.
• Continued PRP involvement is crucial for patient-centered advancements in psoriatic disease research.